Claims for Patent: 4,416,874
✉ Email this page to a colleague
Summary for Patent: 4,416,874
Title: | Injectable compositions of BBM-928A |
Abstract: | BBM-928A solutions suitable for parenteral use in animal experiments and having concentrations in the range of 1 mg/ml to 5 mg/ml are described. |
Inventor(s): | Kaplan; Murray A. (Syracuse, NY), Shinal; Edward C. (Manlius, NY) |
Assignee: | Bristol-Myers Company (New York, NY) |
Application Number: | 06/354,998 |
Patent Claims: | 1. A pharmaceutical composition suitable for intravenous injection comprising a sterile aqueous solution containing from 1 mg. to 5 mg. of BBM 928A per milliliter, and
sufficient of a pharmaceutically acceptable water soluble base to solubilize said BBM 928A and confer a pH value of from pH 11.0 to 11.5 upon said solution wherein said base is selected from the group consisting of sodium hydroxide, trisodium phosphate,
sodium carbonate, pyrrolidine, triethylamine, piperidine, glucosamine, N-methylglucamine, and the sodium salt of an organic acid selected from the group consisting of glycine, aspartic acid, cysteine, phthalic acid, succinic acid, and tyrosine.
2. The intravenous solution of claim 1 wherein said base is sodium hydroxide. 3. The intravenous solution of claim 1 wherein said base is trisodium orthophosphate. 4. The intravenous solution of claim 1 wherein said base is the sodium salt of glycine, aspartic acid, cysteine, phthalic acid, succinic acid, or tyrosine. 5. The intravenous solution of claim 1 wherein said base is pyrrolidine, triethylamine, or piperidine. 6. A dry composition suitable for constitution with sterile water for injection comprising one part by weight of BBM 928A and 0.65 parts by weight of trisodium orthophosphate. 7. The composition of claim 6 in dosage unit form providing 10 mg. of BBM 928A for constitution with 2 milliliters of water. 8. A pharmaceutical composition suitable for intravenous injection comprising a sterile aqueous solution containing one part by weight of BBM 928A and 0.65 parts by weight of trisodium orthophosphate and sufficient water to provide a BBM 928A concentration of from 1 to 5 mg. per milliliter. |
Details for Patent 4,416,874
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Merck Sharp & Dohme Corp. | ZOSTAVAX | zoster vaccine live | For Injection | 125123 | 05/25/2006 | ⤷ Try a Trial | 2039-09-23 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.